Asian Journal of Research in Pharmaceutical Sciences

  • Year: 2025
  • Volume: 15
  • Issue: 2

Pharmaceutical industry dynamics: Production, consumption, and trade in OIC member countries

  • Author:
  • Rehan Haider1,*, Asghar Mehdi2, Geetha Kumari Das3, Zameer Ahmed4, Sambreen Zameer5
  • Total Page Count: 8
  • Published Online: Sep 3, 2025
  • Page Number: 191 to 198

1Head of Marketing and Sales, Riggs Pharmaceuticals, Department of Pharmacy, University of Karachi, Pakistan

2Head, Department of Pharmacology, Fazaia Ruth Pfau Medical College Air College, Karachi, Pakistan

3GD Pharmaceutical Inc, OPJS University, Rajasthan, India

4Assistant Professor, Dow University of Health Sciences, Karachi, Pakistan

5Department of Pathology, Dow University of Health Sciences, Karachi, Pakistan

Abstract

Drug manufacturing plays a pivotal role in all-encompassing healthcare, particularly in Organization of Islamic Cooperation (OIC) appendage nations. This paper delves into the dynamics of drug results, consumption, and work within this diverse group of countries and their governments.

OIC nations exhibit a wide range of drug production volumes, varying from advanced production abilities to those reliant on imports. Factors doing result include supervisory foundations, technological progress, and expense climates.

The demand for pharmaceuticals within OIC appendage nations is affected by population headcount, affliction prevalence, healthcare foundation, and socio-business-related factors. Rising incomes and changeful behaviors contribute to increased use, especially for incessant afflictions and innovative analyses.

Intra-OIC drug trade is important, compelled by diverse determinants such as geographic closeness, professional agreements, and financial unification initiatives. Export-familiarized nations influence competitive benefits in terms of result costs and quality principles, while significance-dependent countries, with their governments, inquire about access to essential cures and mechanics know-how. Challenges and Opportunities: Despite progress, drug manufacturing in OIC countries faces challenges containing supervisory harmonization, protected property created by original thought rights, and an approach to financing. However, events thrive, including the potential for OIC cooperation, technology transfer, and competency construction to enhance autonomy and meet healthcare needs.

Understanding the action of pharmaceutical results, devouring, and supply with merchandise from OIC member nations is essential for policymakers, manufacturing stakeholders, and worldwide institutions to foster tenable incidents, improve approaches to cures, and promote community health in this place's diverse and active domain.

Keywords

Pharmaceutical manufacturing, OIC appendage countries, Result, Use, Trade, Healthcare, Organizing, Science transfer